Afinida Reports $16.9M in Q3 2025 Revenue, Expands Subsidiary Growth
Afinida (OTCID:TREP) reported Q3 2025 quarterly revenue of $5.0M and year-to-date revenue of $16.9M through Sept. 30, 2025. The company recorded a YTD net loss of $1.37M versus net income of $1.36M in the same period of 2024, which management attributed to strategic reinvestments.
Key operational trends include a 15% quarter-over-quarter revenue increase (+$771k), a $375k (41%) reduction in net loss versus the prior quarter, nearly 20% quarterly growth at Afinida Marketing between Q1 and Q2, and an operating expense reduction of over 15% year-over-year.
Afinida (OTCID:TREP) ha riportato entrate trimestrali del Q3 2025 pari a 5,0 milioni di dollari e entrate cumulative da inizio anno fino al 30 settembre 2025 pari a 16,9 milioni di dollari. L'azienda ha registrato una perdita netta YTD di 1,37 milioni di dollari rispetto a un utile netto di 1,36 milioni nello stesso periodo del 2024, che la direzione attribuisce a reinvestimenti strategici.
Le principali tendenze operative includono un aumento del 15% delle entrate rispetto al trimestre precedente (+771k), una riduzione della perdita netta di 375k dollari (41%) rispetto al trimestre precedente, quasi 20% di crescita trimestrale di Afinida Marketing tra Q1 e Q2, e una riduzione delle spese operative di oltre il 15% su base annua.
Afinida (OTCID:TREP) reportó ingresos del trimestre Q3 2025 de 5,0 millones de dólares y ingresos acumulados del año a la fecha de 16,9 millones de dólares al 30 de septiembre de 2025. La empresa registró una pérdida neta YTD de 1,37 millones de dólares frente a un ingreso neto de 1,36 millones en el mismo periodo de 2024, que la dirección atribuye a reinversiones estratégicas.
Las tendencias operativas clave incluyen un aumento del 15% de los ingresos trimestre a trimestre (+771k), una reducción de la pérdida neta de 375k dólares (41%) respecto al trimestre anterior, casi un crecimiento trimestral del 20% en Afinida Marketing entre Q1 y Q2, y una reducción de los gastos operativos de más del 15% interanual.
Afinida (OTCID:TREP)는 2025년 3분기에 5.0백만 달러의 매출과 2025년 9월 30일 기준 연간 누적 매출 16.9백만 달러를 보고했습니다. 회사는 2024년 같은 기간의 순이익 1.36백만 달러에 비해 연간 누적 순손실 1.37백만 달러를 기록했으며, 이는 경영진이 전략적 재투자에 기인한다고 설명했습니다.
주요 운영 추세로는 전분기 대비 매출 15% 증가 (+77.1만 달러), 전 분기 대비 순손실 37.5만 달러 감소(41%), Q1과 Q2 사이의 Afinida Marketing의 분기당 약 20% 성장, 그리고 전년 대비 영업비용 15% 이상 감소가 포함됩니다.
Afinida (OTCID:TREP) a annoncé un chiffre d'affaires trimestriel du T3 2025 de 5,0 M$ et un chiffre d'affaires annuel cumulé jusqu'au 30 septembre 2025 de 16,9 M$. L'entreprise a enregistré une perte nette YTD de 1,37 M$ contre un bénéfice net de 1,36 M$ au cours de la même période en 2024, que la direction attribue à des réinvestissements stratégiques.
Les tendances opérationnelles clés comprennent une augmentation de 15% des revenus trimestre sur trimestre (+771k$), une réduction de la perte nette de 375k$ (41%) par rapport au trimestre précédent, près d'un croissance trimestrielle d'environ 20% chez Afinida Marketing entre le T1 et le T2, et une réduction des dépenses d'exploitation de plus de 15% d'une année sur l'autre.
Afinida (OTCID:TREP) meldete im dritten Quartal 2025 einen Umsatz von 5,0 Mio. USD und einen Year-to-Date-Umsatz von 16,9 Mio. USD bis zum 30. September 2025. Das Unternehmen verzeichnete eine YTD-Nettoverlust von 1,37 Mio. USD gegenüber einem Nettoertrag von 1,36 Mio. USD im gleichen Zeitraum 2024, den das Management auf strategische Reinvestitionen zurückführt.
Wichtige operative Trends umfassen einen 15%-igen Umsatzanstieg gegenüber dem Vorquartal (+771k USD), eine Rückgang des Nettoverlusts um 375k USD (41%) gegenüber dem Vorquartal, nahezu 20%-iges quartalsweises Wachstum bei Afinida Marketing zwischen Q1 und Q2, und eine Überprüfung der Betriebsausgaben um über 15% gegenüber dem Vorjahr.
Afinida (OTCID:TREP) أبلغت عن إيرادات ربعية للربع الثالث من عام 2025 بلغت 5.0 مليون دولار وإيرادات مُجمّعة منذ بداية السنة حتى 30 سبتمبر 2025 بلغت 16.9 مليون دولار حتى 30 سبتمبر 2025. سجلت الشركة خسارة صافية حتى تاريخه للسنة قدرها 1.37 مليون دولار مقابل دخل صافي قدره 1.36 مليون دولار في الفترة نفسها من عام 2024، وهو ما نسبت الإدارة إلى إعادة استثمار استراتيجية.
تشمل الاتجاهات التشغيلية الرئيسية زيادة الإيرادات الربعية بنسبة 15% (+771 ألف دولار)، وانخفاض الخسارة الصافية بمقدار 375 ألف دولار (41%) مقارنة بالربع السابق، ونمو ربع سنوي يقارب 20% في Afinida Marketing بين الربع الأول والربع الثاني، وخفض في المصروفات التشغيلية بأكثر من 15% سنوياً.
- Quarterly revenue of $5.0M
- Year-to-date revenue of $16.9M
- Revenue increase of $771k (15%) quarter-over-quarter
- Operating expenses reduced >15% year-over-year
- Year-to-date net loss $1.37M vs prior-year net income $1.36M
- Net loss remains despite QoQ improvement ($375k reduction)
Parent company continues to strengthen diversified service offerings while positioning for sustainable long-term growth
ESCONDIDO, CA / ACCESS Newswire / November 19, 2025 / Afinida, Inc. (OTCID:TREP) ("Afinida," "the Company") today announced its financial results for the quarter ending September 30, 2025. The Company reported
While the Company recorded a net loss of
Highlights from the Q3 2025 Report include:
Quarterly revenue of
$5.0 million for the quarter ended September 30, 2025Year-to-date revenue of
$16.9 million through the quarter ended September 30, 2025Continued growth from Afinida Marketing, which posted nearly
20% quarterly revenue increase between Q1 and Q2Expansion of Afinida Accounting and Afinida HR Services client portfolios
Operating expense reduction of over
15% year-over-year, reflecting improved cost control and efficiency
Management noted that recent internal improvements and expanded service offerings are expected to deliver stronger results in the fourth quarter and beyond.
Read the full Q3 2025 Quarterly Report and explore additional financial disclosures on Afinida's Investor Page at www.afinida.com/news/investors or follow Afinida on LinkedIn and Meta.
Media Contact:
Glenn Iredale
giredale@afinidamkt.com
(858) 500-5075
SOURCE: Afinida, Inc.
View the original press release on ACCESS Newswire
FAQ
What revenue did Afinida (TREP) report for Q3 2025?
What is Afinida's year-to-date revenue through Q3 2025 for TREP?
Why did Afinida (TREP) report a net loss in the first nine months of 2025?
How did Afinida's revenue and net loss change quarter-over-quarter in Q3 2025?
Which Afinida subsidiary showed notable growth in 2025?
Where can investors find Afinida's full Q3 2025 report for TREP?
